Targeting extracellular matrix molecules for the treatment of cancer

The present invention relates to an agent able to block a cancer supportive function of a fasciclin protein family member and to pharmaceutical compositions containing the same.


Year:
2011
Other identifiers:
TTO: 6.0886
EPO Family ID: 43063451
Patent number(s):
Laboratories:




 Record created 2015-09-22, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)